Jane Street’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Sell
8,100
-92,500
-92% -$4.99M ﹤0.01% 7703
2026
Q1
$5.26M Buy
100,600
+95,800
+1,996% +$5.75M ﹤0.01% 3436
2025
Q4
$282K Buy
4,800
+1,100
+30% +$66.8K ﹤0.01% 8975
2025
Q3
$206K Buy
+3,700
New +$198K ﹤0.01% 9630
2024
Q3
Sell
-6,300
Closed -$451K 10389
2024
Q2
$451K Sell
6,300
-5,500
-47% -$405K ﹤0.01% 7190
2024
Q1
$831K Sell
11,800
-5,700
-33% -$408K ﹤0.01% 5741
2023
Q4
$1.35M Sell
17,500
-1,000
-5% -$65.9K ﹤0.01% 5023
2023
Q3
$1.26M Buy
18,500
+13,600
+278% +$1.07M ﹤0.01% 4817
2023
Q2
$400K Buy
4,900
+2,100
+75% +$169K ﹤0.01% 6661
2023
Q1
$208K Sell
2,800
-800
-22% -$61.7K ﹤0.01% 7793
2022
Q4
$298K Buy
+3,600
New +$286K ﹤0.01% 7037
2022
Q2
Sell
-2,800
Closed -$303K 10850
2022
Q1
$303K Sell
2,800
-1,200
-30% -$124K ﹤0.01% 8391
2021
Q4
$517K Sell
4,000
-2,800
-41% -$343K ﹤0.01% 7207
2021
Q3
$824K Sell
6,800
-25,600
-79% -$3.12M ﹤0.01% 6298
2021
Q2
$3.65M Buy
32,400
+28,000
+636% +$2.95M ﹤0.01% 3204
2021
Q1
$420K Buy
+4,400
New +$401K ﹤0.01% 7107

Other funds holding TECH

Jane Street's TECH Position: Q2 2026 in Review

Jane Street reduced its Bio-Techne (TECH) stake by 35% in Q2 2026, selling an estimated $130K and leaving 4,458 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #9116.

Jane Street first reported a position in TECH in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.2M in Q2 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Jane Street held 4,458 shares of Bio-Techne worth $315K as of Q2 2026.
  • Jane Street sold 2,403 Bio-Techne shares in Q2 2026, an estimated $130K.
  • Bio-Techne made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9116 holding.
  • Jane Street first reported a position in Bio-Techne in Q2 2013 and has held it in 35 quarters since.
  • Jane Street's Bio-Techne position peaked at $10.2M in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.